Clinical Trial

Zoledronate maintains fat mass in older osteopenic women.

This study found that zoledronate, a medication used for osteoporosis, helped prevent age-related fat mass loss in late postmenopausal women. This suggests a potential benefit beyond bone health, possibly influencing intermediary metabolism and contributing to longevity.